Бидний тухай
Бүтээгдэхүүн
Холбоо барихХязгааргүй брэндийн үнэ цэнэ
Sofol-ийн хийж байгаа зүйл бол хэрэглэгчдэд хэмнэлттэй, тохиромжтой үйлдвэрлэлийн шугамыг тохируулах, брэндийн үнэ цэнийг бий болгох явдал юм.
Нүүр хуудас
021-58386189
Цэс
Sofol-ийн хийж байгаа зүйл бол хэрэглэгчдэд хэмнэлттэй, тохиромжтой үйлдвэрлэлийн шугамыг тохируулах, брэндийн үнэ цэнийг бий болгох явдал юм.
CordenPharma recently acquired a highly potent API site in Boulder, US, which was previously owned by Pfizer. The new facility will be renamed CordenPharma …
Luxembourg, 7 July 2020. CordenPharma is proud to announce peptide manufacturing capacity expansion in CordenPharma Colorado, their GMP API facility in Boulder, CO (US).Already known for its unique large-scale peptide offering with a 10'000 L SPPS (Solid-Phase Peptide Synthesis) vessel, and a 100 cm high-pressure reverse phase purification …
COVID-19 Success Story > CordenPharma Switzerland ramps up supply of high-quality GMP lipids for COVID-19 vaccines under development. > COVID-19 Success Story: Our API facility CordenPharma Switzerland is ramping up supply of high-quality GMP lipids, an important component of drug delivery for promising vaccines under …
CordenPharma Plankstadt has two plants available for the manufacturing of highly potent drug products. Highly potent drug products with a clearly defined OEL/PDE value can either be manufactured in a fully contained facility employing primary containment at a batch size of 100 – 150 kg or in a segregated area within the standard facility.
GMP бол Англи хэл дээр сайн үйлдвэрлэлийн практик гэсэн утгатай Сайн үйлдвэрлэлийн практик гэсэн үг юм. Үйлдвэрлэлийн сайн туршлага нь гоо …
With approximately 350 employees, CordenPharma Colorado has grown a strong focus in the development & manufacturing of APIs from laboratory-scale to commercialization at ton-scale, due to their unique large-scale SPPS capabilities. The purification of the final peptide is performed at any scale using column chromatography, …
With the addition of these three new facilities, CordenPharma's global network now consists of twelve locations (11 GMP sites and 1 R&D laboratory), supported by > 2,600 employees generating ...
CordenPharma. 01 Feb, 2022, 11:45 IST. LUXEMBOURG, Feb. 1, 2022 /PRNewswire/ -- CordenPharma, a leading, full-service Contract Development & Manufacturing …
Press Release > CordenPharma Delivers Strong 2019 Results with 24.2% Sales Increase. CordenPharma is pleased to announce its 2019 year-end financial results, which demonstrated solid organic growth with net sales increase of €75 million (+24.2%) and total sales of €386 million. The company's sales development in 2019 reflected very ...
CordenPharma is a full-service Contract Development & Manufacturing Organization (CDMO) for the production of APIs, Excipients, Drug Products, and associated …
LNP (Lipid Nanoparticle) cross-section shown as a vehicle for drug delivery like RNA and / or peptides. To view an animated version of this LNP – click here. Since the discovery of liposomes by Bangham and Horne in 1964, the use of phospholipids as critical excipients / pharmaceutical additives or Active Pharmaceutical Ingredients (APIs) in the …
LUXEMBOURG, Feb. 1, 2022 /PRNewswire/ -- CordenPharma, a leading, full-service Contract Development & Manufacturing Organization (CDMO) supplying APIs, …
CordenPharma & Wacker Awarded Pandemic Preparedness Contract. CordenPharma and Wacker are honored to be among the companies awarded a stand-by production agreement with the German government to produce mRNA vaccines when needed. After several months of a tendering process, a bidding consortium consisting of CordenPharma and …
In addition to the largest worldwide capacity of commercial SPPS peptide production up to batch sizes exceeding 400 kg (> 35 Amino Acids), and a yearly capacity of > 2 Metric Tons of Peptide, CordenPharma's multi-pronged approach to becoming the #1 peptide CDMO supplier extends to small-scale capabilities, which started with expansions of non-GMP …
Corden Pharma Bergamo staff participate in health monitoring and training programs which are organized as required by current legislation ( Italian law D. Lgs n°81 April 9th 2008 e s.m.i.; D. Lgs. n°105 June 26th 2015). …
CordenPharma Facility Legacy Company Year Acquired CordenPharma Chenôve : Abbott / Solvay: 12 / 2007: CordenPharma Plankstadt: AstraZeneca: 1 / 2008: CordenPharma Caponago: AstraZeneca: 6 / 2009: CordenPharma Switzerland: Sanofi / Genzyme: 2 / 2011: CordenPharma Colorado: Roche: 8 / 2011: CordenPharma Bergamo: Tessenderlo / …
CordenPharma is a well-known expert in synthetic Lipid process development, scale-up and large-scale manufacturing, including custom and standard lipids (Glycero-Phospholipids, Sphingolipids, Phosphocholine, Pegylated, and Cationic Lipids), for which CordenPharma holds several Drug Master Files (DMFs). CordenPharma supports …
About Us >>. Leadership. In 2006 CordenPharma was formed into a full-service CDMO for the supply of APIs, Excipients, Drug Products, and associated Packaging Services. In 2022, the organization was purchased by Private Equity firm Astorg. With 11 cGMP facilities across Europe and the US, CordenPharma is headed by the CordenPharma Executive ...
Сайн үйлдвэрлэлийн практик систем (GMP) нь чанарын стандартын дагуу бүтээгдэхүүнийг үйлдвэрлэж, хяналтанд байлгах боломжийг олгодог систем юм. Олон салбарыг хамарсан энэхүү програм нь ...
Small Molecules. The wide breadth of CordenPharma technologies across all facilities have been organized into Technology Platforms to provide integrated full-service capabilities. CordenPharma Technology Platforms are supported by our global supply chain spanning the development of intermediates & APIs, formulation services and commercial cGMP ...
Drug Product Contract Manufacturing. CordenPharma's state-of-the-art formulation facilities are equipped to manufacture solid dose and parenteral formulations. The broad spectrum of capabilities allows formulations of highly potent and oncological compounds. Handling of sterile powder-filled vials, lyophilized vials, oral suspension powders ...
CordenPharma stands above the competition with trained professionals who adhere to the highest possible regulatory standards at all stages of product development. Analytical Support Throughout the whole development and industrial lifecycle of all of our APIs we provide analytical support for contracted customers as required to be cGMP compliant.
Luxembourg, 28 May 2020. CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agreement with Moderna, Inc. (Nasdaq: MRNA), a clinical stage …
Facility Legacy. CordenPharma Colorado is a world leader in the development and manufacturing of chemically synthesized peptide APIs. Starting as a technology-based contract manufacturing business in 1946, it has contributed important technical advances to API manufacturing, most recently in the fields of highly active compounds and peptide ...
As a demonstration of our fully-integrated supply chain expertise, we would like to highlight a recent case study developed in our CordenPharma Caponago facility on the Injectable Drug-Device Combination Product …
In addition, together with our Solid State Centre of Excellence in CordenPharma Liestal, Switzerland, we now provide a fully-integrated API and Drug Product development approach by combining the optimal physical API form required with a drug product formulation that allows for sufficient absorption / solubility, stability, and processability.
Full-Service, Fully Committed. CordenPharma is a full-service Contract Development & Manufacturing Organization (CDMO) for the production of APIs, Excipients, Drug Products, and associated Packaging Services. Through a growing network of focused investments across Europe and the US organized under Technology Platforms, CordenPharma …
Онлайн чат
Шууд утас